Streetbeat News

Corporate Responsibility

OFIX

Orthofix Medical has appointed Massimo Calafiore as President, CEO, and Board Member, effective immediately. Julie Andrews has been named CFO, with her role commencing on January 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:09 pm

RVNC

Revance Therapeutics provided a corporate update, preliminary financial results for Q4 and FY23, and a financial outlook. The company expects Q4 DAXXIFY revenue to be between $23.5M-$24.5M and FY23 DAXXIFY revenue to be between $83.5M-$84.5M.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:05 pm

MMM

3M (NYSE:MMM) will freeze its U.S. pension plans for non-union employees by Dec. 31, 2028. The freeze affects 3M and the future independent health care company's U.S. pension plans. Current pension-eligible employees will accrue benefits until the freeze date, while former employees with vested benefits and retirees are not affected. The company has been transitioning from pension plans to a 401(k) structure since 2009 to give employees more investment flexibility for retirement.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:03 pm

GEHC

GE HealthCare is set to acquire MIM Software, a provider of AI-enabled image analysis and workflow tools for various care areas. The terms of the acquisition were not disclosed, but it is aimed at enhancing GE HealthCare's precision care strategy and digital solutions.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:02 pm

PZZA

Papa John's International, Inc. reported a preliminary global system-wide sales increase of approximately 5% for FY23, with 210 net new units, including 57 in North America. North America comparable sales also saw a preliminary increase of 1%. The company's long-term strategic initiatives are aimed at driving comparable sales growth and higher AUVs through increased marketing investments in North America, improving restaurant-level margins, boosting net new unit development, and enhancing international operational effectiveness.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:02 pm

ACN

Accenture has made a strategic investment in QuantHealth through Accenture Ventures. The financial terms of the investment were not disclosed. This move could potentially enhance Accenture's capabilities in the health technology sector by leveraging QuantHealth's expertise.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 1:02 pm

ENVX

Enovix and Group14 have announced a collaboration to develop and enhance the performance and efficiency of lithium-ion silicon batteries, aligning with their dedication to innovation, renewable energy, and customer satisfaction.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:55 pm

RPTX

Repare Therapeutics has provided a corporate update, outlining key milestones expected in 2024. The company concluded 2023 with about $223 million in cash, cash equivalents, and marketable securities. This financial position is projected to support its planned operations until mid-2026.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:48 pm

XOMA

XOMA Corporation has appointed Owen Hughes as the CEO and Jack Wyszomierski as the Chairman of the Board. Hughes has been serving as XOMA's Executive Chairman and Interim CEO since January 1, 2023.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:44 pm

MRKR

Marker Therapeutics announced a strategic prioritization of its clinical programs, emphasizing the development of MT-601 for patients with lymphoma. This decision indicates a refocusing of the company's resources and efforts on advancing this particular treatment, which may have implications for its pipeline and financial allocations.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:30 pm